CLEC9A and neoplasm: Several drugs that block the entry of the virus have been developed such as maraviroc (MVC), which also blocks CCR5 signaling and migration in response to CCL5.35 To assess whether the CCL5/CCR5 axis is responsible for the enhanced accumulation of cDC1s in tumors from FL-treated mice in DNGR-1-deficient settings, we tested the effect of MVC in tumor growth and DC infiltration.